Inventor · disambiguated record
Robert H. Zimmer
Also filed as: ZIMMER ROBERT · ZIMMER ROBERT H
15 granted patents·8 pending applications·290 citations·filing 1998–2021
90Inventor score
Top patents by PatentIndex Score
23 records- 0194US6027748APharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorptionJAGOTEC AG·Filed 1998·Granted Feb 22, 2000·194 cites·15 claims
- 0285US6221395B1Controlled release pharmaceutical tablets containing an active principle of low water solubilityJAGOTEC AG·Filed 1998·Granted Apr 24, 2001·76 cites·4 claims
- 0384US7691807B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themCENTRE NAT RECH SCIENT·Filed 2006·Granted Apr 6, 2010·7 cites·28 claims
- 0476US8138145B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themVIOLETTE AUDE·Filed 2010·Granted Mar 20, 2012·4 cites·9 claims
- 0572US10398750B2Peptide-oligourea chimeric compounds and methods of their useUREKA SARL·Filed 2014·Granted Sep 3, 2019·1 cites·10 claims
- 0668US10213482B2Methods of treating chronic inflammatory diseasesCENTRE NAT RECH SCIENT·Filed 2015·Granted Feb 26, 2019·1 cites·16 claims
- 0763US6908900B2Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredientsZIMMER & ASSOCIATES AG·Filed 2002·Granted Jun 21, 2005·4 cites·14 claims
- 0862US7671029B2Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substancesIMMUPHARMA SA·Filed 2004·Granted Mar 2, 2010·3 cites·19 claims
- 0959US10889627B2Pro-drug peptide with improved pharmaceutical propertiesUREKA SARL·Filed 2018·Granted Jan 12, 2021·0 cites·29 claims
- 1059US2020155637A1Peptide-oligourea chimeric compounds and methods of their useUREKA SARL·Filed 2019·Application pending·0 cites
- 1156US11267861B2Peptide-oligourea foldamer compounds and methods of their useUREKA SARL·Filed 2017·Granted Mar 8, 2022·0 cites·10 claims
- 1255US2021122800A1Pro-drug peptide with improved pharmaceutical propertiesUREKA SARL·Filed 2020·Application pending·0 cites
- 1353US9657072B2Modified peptides and their use for treating autoimmune diseasesCENTRE NAT DE LA RECHERECHE SCIENT·Filed 2014·Granted May 23, 2017·0 cites·11 claims
- 1451US2021308211A1Method of treating viral infectionsIMMUPHARMA FRANCE SA·Filed 2021·Application pending·0 cites
- 1548US2003060413A1Derivatives of pseudo-peptides, their preparation and their biological usesFiled 2002·Application pending·0 cites
- 1646US2003186849A1Modified peptides and their use for the treatment of autoimmune diseasesFiled 2002·Application pending·0 cites
- 1746US2019352341A1Modified peptides and their use for treating systemic lupus erythematosusIMMUPHARMA FRANCE SA·Filed 2019·Application pending·0 cites
- 1846US2017226167A1Modified peptides and their use for treating autoimmune diseasesCENTRE NAT DE LA RACHERCHE SCIENT (CNRS)·Filed 2017·Application pending·0 cites
- 1944US11285219B2Peptide-oligourea hybrid compoundsUREKA SARL·Filed 2020·Granted Mar 29, 2022·0 cites·11 claims
- 2042US2019142905A1Peptide-oligourea foldamer compounds and methods of their useUREKA SARL·Filed 2018·Application pending·0 cites
- 2139US9243030B2Optically pure compounds for improved therapeutic efficiencyBRIAND JEAN PAUL·Filed 2008·Granted Jan 26, 2016·0 cites·22 claims
- 2238US8080519B2Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substancesZIMMER ROBERT H·Filed 2010·Granted Dec 20, 2011·0 cites·14 claims
- 2333US9487559B2Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycansZIMMER ROBERT·Filed 2011·Granted Nov 8, 2016·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Robert H. Zimmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →